Home
Biofarma

Biofarma Market Share Analysis for June 2026

Santral sinir sistemi, psikoleptikler, hipnotikler ve sedatifler, Melatonin reseptörü agonistleri Cozymel 3mg Tablet KT Cozymel 3mg Tablet KUB Etken Madde: 3 mg Melatonin Alt Terapötik Alan: Melatonin Reseptör Agonistleri Ticari Form: 3 mg 30 Tablet

Health > Biotechnology and Pharmaceuticals

Domainbiofarma.it

Year Founded1945

Employees501 - 1000

Annual Revenue$50M - $75M

Biofarma

Biofarma (including company regionals)

biofarma.it

See more website traffic and engagement information

Biofarma Revenue up to June 2026 is 50M - 75M

revenue generated by Biofarma top domains

Biofarma top domains revenue over 3 years

Revenue for Biofarma top domains

biofarma.it50M - 75M

See more with Sales Intelligence

Total visits to Biofarma's top domains

Understand Biofarma market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Biofarma's top domains

Analyze Biofarma engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Biofarma's top domains

See how Biofarma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Biofarma top competitors by domain

Top similar sites in June 2026, ranked by their affinity

ofi.itCompany NameOfficina Farmaceutica Italiana SpAEmployees51 - 200HQItaly, BergamoAnnual revenue$10M - $15MTotal visits1.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Biofarma

These are the website technologies, by industry, used by Biofarma top domains

Audio Video Media (3)

YouTube

Mobile (3)

Meta Viewport

Widget (3)

Twemoji

Advertising (1)

PubMatic

More Technologies

5

See all

News & Signals from Biofarma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBiofarma Group hires Gianfranco Nazzi as CEO.The Biofarma Group, a contract manufacturer of supplements, medical devices, probiotic-based drugs and cosmetics exclusively for third parties, has appointed Gianfranco Nazzi as its new CEO.